Advanced
Product
Craft Intelligence Portal
Craft API
Supplier Intelligence Platform
Company Search (Free)
Solutions
Craft for Supply Chain
Craft for Sales Intelligence
Aerospace and Defense
Cybersecurity Health Scan
Diverse Supplier Spend Report
Semiconductor Industry Intelligence
ESG Health Scan
Resources
Resource center
Case studies
Product brochures
Blog
Data Partners
Company
About
Careers
Contact us
Overview
Locations
Financials
Operating Metrics
Key People
Revenue
Home
/
ImmunGene
/
Financials & Metrics
ImmunGene stock price, funding rounds, valuation and financials
ImmunGene has raised $9 m in total funding
View Company
Get notified regarding key financial metrics and revenue changes at ImmunGene
Learn more
ImmunGene Funding
Summary Metrics
Founding Date
2007
ImmunGene total Funding
$9 m
ImmunGene latest funding size
$9 m
Time since last funding
9 years ago
ImmunGene investors
Ally Bridge Group
ImmunGene's latest funding round in November 2013 was reported to be $9 m. In total, ImmunGene has raised $9 m
ImmunGene Capital Raised
Embed Graph
View ImmunGene profile
Competitors
Faraday Pharmaceuticals
Healthcare - Private
Tiburio Therapeutics
Healthcare - Private
Vita Therapeutics
Healthcare - Private
LimmaTech Biologics
Healthcare - Private
Compare competitors